Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 11/15/2019
Closing price: 282.27
|Support price level:||$255.14|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||37.2|
- BIIB is one of this month's top performers with a return of 28.3 percent, beating 90 percent of stocks in the S&P-100.
- Down 3.7 percent, BIIB is one of this week's biggest decliners.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 41.5%.
- Volatility is forecast to fall over the next month.
- BIIB is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 11.3% in the next week.
- 21.4% in the next month.
- 86.0% in the next year.